세계의 소화제 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

Digestive Remedies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,964,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,171,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,844,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 전 세계 소화제 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다.

주요 인사이트

• 소화제 시장 규모(2024년) : 197억 3,186만 1,000달러
• 예측 시장 규모(2033년) : 285억 7,442만 6,000달러
• 세계 시장 성장률(CAGR 2024-2033년까지) : 4.2%

소화제 시장 - 조사 범위

소화제에는 소화 불량, 산성 역류, 변비, 과민성 장 증후군(IBS)과 같은 소화기계의 건강 문제를 치료하기 위한 광범위한 제품이 포함됩니다. 시장은 제산제, 완하제, 설사, 프로바이오틱스 등 제품 유형별, 소매 약국, 병원 약국, 전자상거래 플랫폼 등 최종 용도 부문별로 구분됩니다.

시장 성장 촉진요인:

세계의 소화기계 치료 시장은 소화기계 질환과 생활 습관병 증가에 의해 시판(OTC) 소화기계 제품 수요가 급증하고 있는 것으로 견인하고 있습니다. 창자 건강에 대한 소비자의 의식 증가와 자기 치료 지향 증가도 이 시장의 확대를 뒷받침하고 있습니다. 일부 지역에서는 고령화로 소화기계의 문제가 발생하기 쉬워지고 있어 소화기계 치료 수요를 더욱 밀어 올리고 있습니다. 게다가 가공식품의 소비 증가, 앉기 쉬운 라이프스타일, 스트레스가 소화기계 문제의 유병률 상승에 기여하고 있어 시장의 성장을 가속하고 있습니다. 또, 허브나 천연 소화제의 채용 등, 제품 처방의 기술적 진보도 건강 지향의 소비자에게 어필하고 있습니다.

시장 성장 억제요인:

큰 성장 가능성이 있음에도 불구하고 소화 기관용 치료 시장은 엄격한 규제 요구 사항, 특히 완하제 및 제산제와 같은 특정 소화 기관 치료의 장기 사용으로 인한 부작용에 대한 우려와 같은 문제에 직면 해 있습니다. 또 원재료 가격의 변동이나 선진적인 소화기계 치료 중에는 고가의 것도 있어 시장 성장의 억제요인이 되고 있습니다. 게다가 의약품의 소화기관용 제품의 대체품으로서 자연요법이나 영양보조식품을 선호하는 경향이 강해져 일부 지역에서는 기존의 소화기관용 치료의 성장이 제한될 수 있습니다. 이러한 과제를 해결하기 위해 신흥국 시장 진출 기업은 안전하고 자연스럽고 혁신적인 소화기 건강 보조제 개발에 주력하고 있습니다.

시장 기회:

소화기계 치료 시장은 특히 프로바이오틱스와 프리바이오틱스 부문에서 장의 건강을 유지하는 역할을 인식하고 있으며, 여러 성장 기회를 제공합니다. 예방 의학에 대한 관심 증가와 더불어 천연 재료와 식물 유래 소화기계 솔루션을 요구하는 소비자의 요구는 기술 혁신과 제품 개발의 큰 기회가 됩니다. 전자상거래 부문의 확대는 또한 시장 진출기업이 보다 폭넓은 소비자층에 도달할 수 있는 기회를 제공하고 OTC 소화제에 대한 쉬운 접근을 제공합니다. 게다가 IBS와 크론병과 같은 특정 소화기 질환에 대한 맞춤형 의료 및 표적 요법에 대한 관심 증가는 시장 성장의 새로운 길을 열고 있습니다.

이 보고서에서 다루는 주요 질문

• 소화제 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 소화제 부문에서 가장 수요가 높은 제품 유형은?
• 기술 진보와 제품 혁신은 경쟁 구도에 어떤 영향을 미치는가?
• 소화기관 치료 시장의 주요 진출기업은 누구이며 시장의 관련성을 유지하기 위해 어떤 전략을 사용하고 있는가?
• 소화제 시장의 미래를 형성하는 새로운 동향과 기회는 무엇인가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
  • 프리바이오틱스의 이점에 관한 소비자의 의식 향상
  • 소아용 소화 효소 수요가 증가
• 제품 혁신/개발 동향

제4장 중요한 성공 요인

• 제품의 채용/사용 상황 분석
• 제품 USP/특징

제5장 세계 시장 - 가격 분석

• 지역별 가격 분석
• 세계 평균 가격 분석 벤치마크

제6장 세계 시장 수요(가치 USD Mn) 분석

• 과거 시장 매출(100만 달러) 분석, 2019-2023년
• 현재와 장래 시장 매출(100만 달러) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대 수익 기회

제7장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 밸류체인
• 세계의 식음료 업계의 전망
• 세계의 제약 업계 개요
• 정책의 전개와 규제의 시나리오
• 시장 역학
• 세계 수급 분석

제8장 제품 유형별 세계 시장 분석

• 소개
• 2019-2023년의 제품 유형별 시장 규모(100만 달러)와 수량 분석
• 현재와 장래 시장 규모(100만 달러)와 제품 유형별 수량 분석과 예측, 2024-2033년
  • 캡슐
  • 액체/음료
  • 분말
  • 젤
  • 기타(정제, 타블렛, 구미)
• 제품 유형별 시장의 매력 분석

제9장 공급원별 세계 시장 분석

• 소개
• 2019-2023년공급원별 시장 규모(100만 달러)와 수량 분석
• 현재와 장래 시장 규모(100만 달러)와 공급원별 수량 분석과 예측, 2024-2033년
  • 프리바이오틱스
  • 프로바이오틱스
  • 식품 효소
• 공급원별 시장의 매력 분석

제10장 성질별 세계 시장 분석

• 소개
• 2019-2023년의 성질별 시장 규모(100만 달러)와 수량 분석
• 현재와 장래 시장 규모(100만 달러)와 성질별 수량 분석과 예측, 2024-2033년
  • 유기농
  • 기존
• 성질별 시장의 매력 분석

제11장 유통채널별 세계 시장 분석

• 소개
• 2019-2023년 유통채널별 시장 규모(100만 달러)와 수량 분석
• 현재와 장래 시장 규모(100만 달러)와 유통채널별 수량 분석과 예측, 2024-2033년
  • 의약품 및 약국
  • 하이퍼마켓/슈퍼마켓
  • 편의점
  • 직영점
  • 온라인 소매
  • 기타 소매업
• 유통 채널별 시장의 매력 분석

제12장 지역별 세계 시장 분석

• 소개
• 2019-2023년 지역별 시장 규모(100만 달러)와 수량 분석
• 현재 시장 규모(100만 달러)와 지역별 수량 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아와 태평양
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 남아시아와 태평양 시장 분석

제17장 동아시아 시장 분석

제18장 중동 및 아프리카 시장 분석

제19장 국가별 시장 분석, 2024년

• 소개
• 미국
• 캐나다
• 멕시코
• 브라질
• 아르헨티나
• 독일
• 이탈리아
• 프랑스
• 영국
• 스페인
• 폴란드
• 러시아
• 중국
• 일본
• 한국
• 인도
• 호주 및 뉴질랜드
• 터키
• 남아프리카

제20장 시장 구조 분석

• 기업 Tier별 시장 분석(소화제)
• 시장 집중
• 시장현재분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁의 상세
  • Johnson &Johnson, Inc.
  • Bayer AG
  • Sanofi
  • Procter &Gamble Co.
  • Jiangzhong Pharmaceutical Co Ltd
  • Abbott Laboratories Inc.
  • Reckitt Benckiser Group Plc(RB)
  • Takeda Pharmaceutical Co Ltd.
  • Pfizer
  • GlaxoSmithKline Plc
  • Menarini Group
  • Taisho Pharmaceutical Holdings Co Ltd.
  • Purdue Pharma LP
  • Others(Available on Request)

제22장 사용된 전제조건과 약어

제23장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for digestive remedies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Digestive Remedies Market Size (2024E): USD 19731.861 Mn
• Projected Market Value (2033F): USD 28574.426 Mn
• Global Market Growth Rate (CAGR 2024 to 2033): 4.2 %

Digestive Remedies Market - Report Scope:

Digestive remedies include a broad range of products aimed at treating digestive health issues such as indigestion, acid reflux, constipation, and irritable bowel syndrome (IBS). The market is segmented by product type, including antacids, laxatives, anti-diarrheal drugs, and probiotics, and by end-use sectors such as retail pharmacies, hospital pharmacies, and e-commerce platforms.

Market Growth Drivers:

The global digestive remedies market is driven by rising incidences of digestive disorders and lifestyle diseases, which have led to a surge in demand for over-the-counter (OTC) digestive products. Increasing consumer awareness of gut health and the growing preference for self-medication have also supported the expansion of this market. Aging populations in several regions are more prone to digestive problems, further boosting the demand for digestive remedies. Additionally, the rising consumption of processed foods, sedentary lifestyles, and stress are contributing to the increasing prevalence of digestive issues, driving growth in the market. Technological advancements in product formulations, including the introduction of herbal and natural digestive remedies, are also appealing to health-conscious consumers.

Market Restraints:

Despite significant growth potential, the digestive remedies market faces challenges such as stringent regulatory requirements and concerns about the side effects of long-term use of certain digestive drugs, particularly laxatives and antacids. Fluctuations in raw material prices and the high cost of some advanced digestive treatments also pose limitations to market growth. Furthermore, the growing preference for natural remedies and dietary supplements as alternatives to pharmaceutical digestive products could limit the growth of traditional digestive remedies in some regions. To address these challenges, market players are focusing on developing safe, natural, and innovative digestive health products.

Market Opportunities:

The digestive remedies market presents several growth opportunities, particularly in the area of probiotics and prebiotics, which are increasingly recognized for their role in maintaining gut health. The growing interest in preventive healthcare, along with consumer demand for natural and plant-based digestive solutions, offers significant opportunities for innovation and product development. The expanding e-commerce sector also provides an opportunity for market players to reach a broader consumer base, offering easy access to OTC digestive remedies. Furthermore, the increasing focus on personalized medicine and targeted therapies for specific digestive issues, such as IBS and Crohn's disease, is opening up new avenues for market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the digestive remedies market globally?
• Which product types are witnessing the highest demand in the digestive remedies sector?
• How are technological advancements and product innovations influencing the competitive landscape?
• Who are the key players in the digestive remedies market, and what strategies are they using to maintain market relevance?
• What emerging trends and opportunities will shape the future of the digestive remedies market?

Competitive Intelligence and Business Strategy:

Leading players in the global digestive remedies market, including Bayer AG, GlaxoSmithKline Plc, and Johnson & Johnson, are focusing on expanding their product portfolios with a range of digestive health solutions, including both traditional pharmaceuticals and natural remedies. These companies are investing in research and development to create innovative formulations with improved efficacy and fewer side effects. Collaborations with healthcare professionals, pharmacies, and e-commerce platforms are key strategies for promoting digestive remedies to a broader audience. Furthermore, sustainability initiatives, such as eco-friendly packaging and responsible sourcing of natural ingredients, are gaining importance as consumer preferences shift towards more environmentally conscious products.

Companies Covered in This Report

• Johnson & Johnson, Inc
• Bayer AG
• Sanofi
• Procter & Gamble Co.
• Jiangzhong Pharmaceutical Co Ltd
• Abbott Laboratories Inc.
• Reckitt Benckiser Group Plc (RB)
• Takeda Pharmaceutical Co Ltd.
• Pfizer
• GlaxoSmithKline Plc
• Menarini Group
• Taisho Pharmaceutical Holdings Co Ltd.
• Purdue Pharma LP

Digestive Remedies Industry Research by Category

By Product Type:

• Capsules
• Liquid/Drinkable
• Powder
• Gels
• Others(Pills, Tablet, Gummy)

By Nature:

• Organic
• Conventional

By Source:

• Prebiotic
• Probiotic
• Food Enzymes

By Sales Channel:

• Pharmaceutical & Drug Store
• Hypermarket/Supermarket
• Convenience Store
• Direct Store
• Online Retail
• Other Retail Format

By Region:

• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
  • 3.1.1. Increasing Consumer Awareness on Benefits of Prebiotics
  • 3.1.2. High Demand of Pediatric Digestive Enzymes
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features

5. Global Market - Pricing Analysis

• 5.1. Regional Pricing Analysis
• 5.2. Global Average Pricing Analysis Benchmark

6. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 6.2.1. Y-o-Y Growth Trend Analysis
  • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

• 7.1. Macro-Economic Factors
  • 7.1.1. Global GDP Growth Outlook
  • 7.1.2. Global GDP and Infrastructure Investment
  • 7.1.3. International Trade
  • 7.1.4. Global Industry Outlook
• 7.2. Forecast Factors - Relevance & Impact
  • 7.2.1. Top Companies Historical Growth
  • 7.2.2. GDP Growth forecast
  • 7.2.3. Manufacturing Industry forecast
  • 7.2.4. Global Urbanization Growth Outlook
  • 7.2.5. Business Climate
• 7.3. Value Chain
  • 7.3.1. Raw Material Suppliers
  • 7.3.2. Product Manufacturers
  • 7.3.3. Application Sectors
• 7.4. Global Food & Beverage Industry Outlook
• 7.5. Global Pharmaceutical Industry Overview
• 7.6. Policy Developments and Regulatory Scenario
• 7.7. Market Dynamics
  • 7.7.1. Drivers
  • 7.7.2. Restraints
  • 7.7.3. Opportunity Analysis
• 7.8. Global Supply Demand Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
  • 8.3.1. Capsules
  • 8.3.2. Liquid/Drinkable
  • 8.3.3. Powder
  • 8.3.4. Gels
  • 8.3.5. Others (Pills, Tablet, Gummy)
• 8.4. Market Attractiveness Analysis By Product Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Source

• 9.1. Introduction
• 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Source, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Source, 2024-2033
  • 9.3.1. Prebiotic
  • 9.3.2. Probiotic
  • 9.3.3. Food Enzymes
• 9.4. Market Attractiveness Analysis By Source

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Nature

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Nature, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Nature, 2024-2033
  • 10.3.1. Organic
  • 10.3.2. Conventional
• 10.4. Market Attractiveness Analysis By Nature

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Sales Channel

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2024-2033
  • 11.3.1. Pharmaceutical & Drug Store
  • 11.3.2. Hypermarket/Supermarket
  • 11.3.3. Convenience Store
  • 11.3.4. Direct Store
  • 11.3.5. Online Retail
  • 11.3.6. Other Retail Format
• 11.4. Market Attractiveness Analysis By Sales Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
• 12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia and Pacific
  • 12.3.6. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product Type
  • 13.3.3. By Source
  • 13.3.4. By Nature
  • 13.3.5. By Sales Channel
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product Type
  • 13.4.3. By Source
  • 13.4.4. By Nature
  • 13.4.5. By Sales Channel
• 13.5. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Product Type
  • 14.3.3. By Source
  • 14.3.4. By Nature
  • 14.3.5. By Sales Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Source
  • 14.4.4. By Nature
  • 14.4.5. By Sales Channel
• 14.5. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Poland
    • 15.3.1.9. Rest of Europe
  • 15.3.2. By Product Type
  • 15.3.3. By Source
  • 15.3.4. By Nature
  • 15.3.5. By Sales Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Product Type
  • 15.4.2. By Source
  • 15.4.3. By Nature
  • 15.4.4. By Sales Channel
• 15.5. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. ASEAN
    • 16.3.1.3. Oceania
    • 16.3.1.4. Rest of South Asia & Pacific
  • 16.3.2. By Product Type
  • 16.3.3. By Source
  • 16.3.4. By Nature
  • 16.3.5. By Sales Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Source
  • 16.4.4. By Nature
  • 16.4.5. By Sales Channel
• 16.5. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product Type
  • 17.3.3. By Source
  • 17.3.4. By Nature
  • 17.3.5. By Sales Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Source
  • 17.4.4. By Nature
  • 17.4.5. By Sales Channel
• 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC
    • 18.3.1.2. Turkey
    • 18.3.1.3. Nigeria
    • 18.3.1.4. South Africa
    • 18.3.1.5. Rest of Middle East & Africa
  • 18.3.2. By Product Type
  • 18.3.3. By Source
  • 18.3.4. By Nature
  • 18.3.5. By Sales Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product Type
  • 18.4.3. By Source
  • 18.4.4. By Nature
  • 18.4.5. By Sales Channel
• 18.5. Drivers and Restraints - Impact Analysis

19. Country Wise Market Analysis, 2024

• 19.1. Introduction
  • 19.1.1. Market Value Proportion Analysis, By Key Countries
  • 19.1.2. Global Vs. Country Growth Comparison
• 19.2. U.S. Market Analysis
  • 19.2.1. By Product Type
  • 19.2.2. By Source
  • 19.2.3. By Nature
  • 19.2.4. By Sales Channel
• 19.3. Canada Market Analysis
  • 19.3.1. By Product Type
  • 19.3.2. By Source
  • 19.3.3. By Nature
  • 19.3.4. By Sales Channel
• 19.4. Mexico Market Analysis
  • 19.4.1. By Product Type
  • 19.4.2. By Source
  • 19.4.3. By Nature
  • 19.4.4. By Sales Channel
• 19.5. Brazil Market Analysis
  • 19.5.1. By Product Type
  • 19.5.2. By Source
  • 19.5.3. By Nature
  • 19.5.4. By Sales Channel
• 19.6. Argentina Market Analysis
  • 19.6.1. By Product Type
  • 19.6.2. By Source
  • 19.6.3. By Nature
  • 19.6.4. By Sales Channel
• 19.7. Germany Market Analysis
  • 19.7.1. By Product Type
  • 19.7.2. By Source
  • 19.7.3. By Nature
  • 19.7.4. By Sales Channel
• 19.8. Italy Market Analysis
  • 19.8.1. By Product Type
  • 19.8.2. By Source
  • 19.8.3. By Nature
  • 19.8.4. By Sales Channel
• 19.9. France Market Analysis
  • 19.9.1. By Product Type
  • 19.9.2. By Source
  • 19.9.3. By Nature
  • 19.9.4. By Sales Channel
• 19.10. U.K. Market Analysis
  • 19.10.1. By Product Type
  • 19.10.2. By Source
  • 19.10.3. By Nature
  • 19.10.4. By Sales Channel
• 19.11. Spain Market Analysis
  • 19.11.1. By Product Type
  • 19.11.2. By Source
  • 19.11.3. By Nature
  • 19.11.4. By Sales Channel
• 19.12. Poland Market Analysis
  • 19.12.1. By Product Type
  • 19.12.2. By Source
  • 19.12.3. By Nature
  • 19.12.4. By Sales Channel
• 19.13. Russia Market Analysis
  • 19.13.1. By Product Type
  • 19.13.2. By Source
  • 19.13.3. By Nature
  • 19.13.4. By Sales Channel
• 19.14. China Market Analysis
  • 19.14.1. By Product Type
  • 19.14.2. By Source
  • 19.14.3. By Nature
  • 19.14.4. By Sales Channel
• 19.15. Japan Market Analysis
  • 19.15.1. By Product Type
  • 19.15.2. By Source
  • 19.15.3. By Nature
  • 19.15.4. By Sales Channel
• 19.16. S. Korea Market Analysis
  • 19.16.1. By Product Type
  • 19.16.2. By Source
  • 19.16.3. By Nature
  • 19.16.4. By Sales Channel
• 19.17. India Market Analysis
  • 19.17.1. By Product Type
  • 19.17.2. By Source
  • 19.17.3. By Nature
  • 19.17.4. By Sales Channel
• 19.18. Australia and New Zealand Market Analysis
  • 19.18.1. By Product Type
  • 19.18.2. By Source
  • 19.18.3. By Nature
  • 19.18.4. By Sales Channel
• 19.19. Turkey Market Analysis
  • 19.19.1. By Product Type
  • 19.19.2. By Source
  • 19.19.3. By Nature
  • 19.19.4. By Sales Channel
• 19.20. South Africa Market Analysis
  • 19.20.1. By Product Type
  • 19.20.2. By Source
  • 19.20.3. By Nature
  • 19.20.4. By Sales Channel

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies (Digestive Remedies)
• 20.2. Market Concentration
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Deep Dive
  • 21.2.1. Johnson & Johnson, Inc.
    • 21.2.1.1. Overview
    • 21.2.1.2. Product Portfolio
    • 21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.1.4. Sales Footprint
    • 21.2.1.5. Strategy Overview
  • 21.2.2. Bayer AG
    • 21.2.2.1. Overview
    • 21.2.2.2. Product Portfolio
    • 21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.2.4. Sales Footprint
    • 21.2.2.5. Strategy Overview
  • 21.2.3. Sanofi
    • 21.2.3.1. Overview
    • 21.2.3.2. Product Portfolio
    • 21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.3.4. Sales Footprint
    • 21.2.3.5. Strategy Overview
  • 21.2.4. Procter & Gamble Co.
    • 21.2.4.1. Overview
    • 21.2.4.2. Product Portfolio
    • 21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.4.4. Sales Footprint
    • 21.2.4.5. Strategy Overview
  • 21.2.5. Jiangzhong Pharmaceutical Co Ltd
    • 21.2.5.1. Overview
    • 21.2.5.2. Product Portfolio
    • 21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.5.4. Sales Footprint
    • 21.2.5.5. Strategy Overview
  • 21.2.6. Abbott Laboratories Inc.
    • 21.2.6.1. Overview
    • 21.2.6.2. Product Portfolio
    • 21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.6.4. Sales Footprint
    • 21.2.6.5. Strategy Overview
  • 21.2.7. Reckitt Benckiser Group Plc (RB)
    • 21.2.7.1. Overview
    • 21.2.7.2. Product Portfolio
    • 21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.7.4. Sales Footprint
    • 21.2.7.5. Strategy Overview
  • 21.2.8. Takeda Pharmaceutical Co Ltd.
    • 21.2.8.1. Overview
    • 21.2.8.2. Product Portfolio
    • 21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.8.4. Sales Footprint
    • 21.2.8.5. Strategy Overview
  • 21.2.9. Pfizer
    • 21.2.9.1. Overview
    • 21.2.9.2. Product Portfolio
    • 21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.9.4. Sales Footprint
    • 21.2.9.5. Strategy Overview
  • 21.2.10. GlaxoSmithKline Plc
    • 21.2.10.1. Overview
    • 21.2.10.2. Product Portfolio
    • 21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.10.4. Sales Footprint
    • 21.2.10.5. Strategy Overview
  • 21.2.11. Menarini Group
    • 21.2.11.1. Overview
    • 21.2.11.2. Product Portfolio
    • 21.2.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.11.4. Sales Footprint
    • 21.2.11.5. Strategy Overview
  • 21.2.12. Taisho Pharmaceutical Holdings Co Ltd.
    • 21.2.12.1. Overview
    • 21.2.12.2. Product Portfolio
    • 21.2.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.12.4. Sales Footprint
    • 21.2.12.5. Strategy Overview
  • 21.2.13. Purdue Pharma LP
    • 21.2.13.1. Overview
    • 21.2.13.2. Product Portfolio
    • 21.2.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.13.4. Sales Footprint
    • 21.2.13.5. Strategy Overview
  • 21.2.14. Others (Available on Request)
    • 21.2.14.1. Overview
    • 21.2.14.2. Product Portfolio
    • 21.2.14.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.2.14.4. Sales Footprint
    • 21.2.14.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료